GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,708.60p
   
  • Change Today:
      3.40p
  • 52 Week High: 1,713.00
  • 52 Week Low: 1,316.00
  • Currency: UK Pounds
  • Shares Issued: 4,144.88m
  • Volume: 7,547,306
  • Market Cap: £70,819m
  • RiskGrade: 129

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
18.66% above the market average18.66% above the market average18.66% above the market average18.66% above the market average18.66% above the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
1yr Revenue Growth
27.07% below the market average27.07% below the market average27.07% below the market average27.07% below the market average27.07% below the market average
2.86% above the sector average2.86% above the sector average2.86% above the sector average2.86% above the sector average2.86% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
36.35% below the market average36.35% below the market average36.35% below the market average36.35% below the market average36.35% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
1yr DPS Growth
62.8% below the market average62.8% below the market average62.8% below the market average62.8% below the market average62.8% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
3.70% above the market average3.70% above the market average3.70% above the market average3.70% above the market average3.70% above the market average
25.93% below the sector average25.93% below the sector average25.93% below the sector average25.93% below the sector average25.93% below the sector average
Price Book Ratio
84.96% below the market average84.96% below the market average84.96% below the market average84.96% below the market average84.96% below the market average
54.17% below the sector average54.17% below the sector average54.17% below the sector average54.17% below the sector average54.17% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
35.50% above the market average35.50% above the market average35.50% above the market average35.50% above the market average35.50% above the market average
50.88% above the sector average50.88% above the sector average50.88% above the sector average50.88% above the sector average50.88% above the sector average
Price Chg 3m
77.28% above the market average77.28% above the market average77.28% above the market average77.28% above the market average77.28% above the market average
68.42% above the sector average68.42% above the sector average68.42% above the sector average68.42% above the sector average68.42% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
33.81% above the market average33.81% above the market average33.81% above the market average33.81% above the market average33.81% above the market average
59.26% above the sector average59.26% above the sector average59.26% above the sector average59.26% above the sector average59.26% above the sector average
Momentum 20
83.45% above the market average83.45% above the market average83.45% above the market average83.45% above the market average83.45% above the market average
92.59% above the sector average92.59% above the sector average92.59% above the sector average92.59% above the sector average92.59% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
39.43% above the market average39.43% above the market average39.43% above the market average39.43% above the market average39.43% above the market average
88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average
ROCE
78.03% above the market average78.03% above the market average78.03% above the market average78.03% above the market average78.03% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
91.70% above the market average91.70% above the market average91.70% above the market average91.70% above the market average91.70% above the market average
88.89% above the sector average88.89% above the sector average88.89% above the sector average88.89% above the sector average88.89% above the sector average
Forecast EPS
81.68% above the market average81.68% above the market average81.68% above the market average81.68% above the market average81.68% above the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
97.63% above the market average97.63% above the market average97.63% above the market average97.63% above the market average97.63% above the market average
94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average
Operating Profit Loss
98.77% above the market average98.77% above the market average98.77% above the market average98.77% above the market average98.77% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
96.73% above the market average96.73% above the market average96.73% above the market average96.73% above the market average96.73% above the market average
96.15% above the sector average96.15% above the sector average96.15% above the sector average96.15% above the sector average96.15% above the sector average
Cash
96.64% above the market average96.64% above the market average96.64% above the market average96.64% above the market average96.64% above the market average
96.30% above the sector average96.30% above the sector average96.30% above the sector average96.30% above the sector average96.30% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
87.85% above the market average87.85% above the market average87.85% above the market average87.85% above the market average87.85% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Buys 1y
90.28% above the market average90.28% above the market average90.28% above the market average90.28% above the market average90.28% above the market average
80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average80.00% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
54.15% below the market average54.15% below the market average54.15% below the market average54.15% below the market average54.15% below the market average
80.95% below the sector average80.95% below the sector average80.95% below the sector average80.95% below the sector average80.95% below the sector average
Brokers Percent Neutral
25.00% above the market average25.00% above the market average25.00% above the market average25.00% above the market average25.00% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,708.60p
Change Today 3.40p
% Change 0.20 %
52 Week High 1,713.00
52 Week Low 1,316.00
Volume 7,547,306
Shares Issued 4,144.88m
Market Cap £70,819m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
83.07% below the market average83.07% below the market average83.07% below the market average83.07% below the market average83.07% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average
Price Trend
50.74% above the market average50.74% above the market average50.74% above the market average50.74% above the market average50.74% above the market average
71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average
Income
31.40% above the market average31.40% above the market average31.40% above the market average31.40% above the market average31.40% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
26.72% below the market average26.72% below the market average26.72% below the market average26.72% below the market average26.72% below the market average
29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average

What The Brokers Say

Strong Buy 7
Buy 6
Neutral 9
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 22-Feb-24 16-Nov-23
Paid 11-Apr-24 11-Jan-24
Amount 16.00p 14.00p

Trades for 28-Mar-2024

Time Volume / Share Price
17:14 750,000 @ 1,709.81p
17:04 13,917 @ 1,706.01p
17:04 13,076 @ 1,706.01p
17:04 549 @ 1,706.01p
17:03 172,458 @ 1,706.01p

GSK Key Personnel

CEO Emma Walmsley

Top of Page